相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
Gong Chen et al.
ONCOTARGET (2017)
Plasma thioredoxin reductase activity, a diagnostic biomarker, is up-regulated in resectable non-small cell lung cancers
Ming Zhou et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation
Elaine Lai-Han Leung et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress
Chaoran Dong et al.
SCIENTIFIC REPORTS (2016)
Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator β-glucan in a two-case ex vivo non-small-cell lung cancer study
Teresa W-M Fan et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2016)
LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
Fuming Li et al.
CANCER CELL (2015)
The role of thioredoxin reductase 1 in melanoma metabolism and metastasis
Pamela B. Cassidy et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
Chunyan Li et al.
ONCOTARGET (2015)
An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer
Nedret Kilic et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
EXPRESSION OF THIOREDOXINS AND GLUTAREDOXINS IN HUMAN HEPATOCELLULAR CARCINOMA: CORRELATION TO CELL PROLIFERATION, TUMOR SIZE AND METABOLIC SYNDROME
A. Mollbrink et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Isocitrate Dehydrogenase 1 Is a Novel Plasma Biomarker for the Diagnosis of Non-Small Cell Lung Cancer
Nan Sun et al.
CLINICAL CANCER RESEARCH (2013)
Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Freddie Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent
Lihui Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning
Pepijn Brocken et al.
LUNG CANCER (2012)
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
M. Grunnet et al.
LUNG CANCER (2012)
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited
Shaohua Ma et al.
CANCER BIOMARKERS (2011)
Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC)
Susana Cedres et al.
CLINICAL LUNG CANCER (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
Arne Holmgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3-and SP-C-associated cell death/injury activity
Yih-Sheng Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
Oscar Arrieta et al.
BMC CANCER (2009)
Delay in diagnosis: the experience in Denmark
F. Olesen et al.
BRITISH JOURNAL OF CANCER (2009)
Tools used in the diagnosis and staging of lung cancer: what's old and what's new?
G. P. Currie et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Preamble: National academy of clinical biochemistry laboratory medicine practice guidelines for utilization of biomarkers in acute coronary syndromes and heart failure
Robert H. Christenson
CLINICAL BIOCHEMISTRY (2008)
The thioredoxin system in cancer
Elias S. J. Arner et al.
SEMINARS IN CANCER BIOLOGY (2006)
Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells
MH Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thioredoxin reductase is irreversibly modified by curcumin - A novel molecular mechanism for its anticancer activity
JG Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development
C Jakupoglu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Adenylyl cyclase-associated protein Aca1 regulates virulence and differentiation of Cryptococcus neoformans via the cyclic AMP protein kinase A cascade
YS Bahn et al.
EUKARYOTIC CELL (2004)
Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function
M Conrad et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The role of the redox protein thioredoxin in cell growth and cancer
G Powis et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
分享论文
